ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.

Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,116
+348.2%
115,889
+396.0%
0.00%
Q2 2023$249
-100.0%
23,365
-91.5%
0.00%
-100.0%
Q4 2021$3,214,000
-66.6%
275,640
-62.5%
0.00%
-66.7%
Q3 2021$9,609,000
+125.2%
735,721
+96.4%
0.01%
+100.0%
Q4 2020$4,266,000
+1346.1%
374,569
+1212.0%
0.01%
+500.0%
Q2 2020$295,000
+94.1%
28,549
+89.1%
0.00%
Q1 2020$152,000
-97.6%
15,100
-96.9%
0.00%
-100.0%
Q4 2019$6,410,000481,6240.02%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$157,835,70021.26%
AlphaCentric Advisors LLC 292,500$2,816,7751.60%
Quantedge Capital Pte Ltd 179,900$1,732,4370.94%
Intrinsic Value Partners, LLC 50,355$484,9190.62%
Brown Capital Management 3,719,796$35,821,6350.55%
ARMISTICE CAPITAL, LLC 3,456,000$33,281,2800.51%
SummerHaven Investment Management, LLC 67,765$652,5770.48%
BRAIDWELL LP 1,348,099$12,982,1930.41%
AFFINITY INVESTMENT ADVISORS, LLC 50,733$488,5590.32%
EMC Capital Management 43,315$4170.31%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders